Dokter Ooforektomi terbaik di dunia — TOP 28

Assoc. Prof. Dr. Esra Ozbasli berspesialisasi dalam ooforektomi invasif minimal dengan pengalaman lebih dari 23 tahun, termasuk pelatihan bedah robotik sejak 2013.

• Dokter kandungan bersertifikat dengan keahlian dalam estetika genital wanita dan uroginekologi
• Melakukan ooforektomi laparoskopi dan dengan bantuan robot untuk hasil pasien yang optimal
• Profesor asosiasi yang melatih mahasiswa kedokteran dan spesialis kandungan dalam teknik bedah
• Anggota komunitas medis internasional dengan sertifikasi ECFMG dan observasi di NYU

Profesor Dr. Mehmet Karaca berspesialisasi dalam kanker ginekologi dan bedah laparoskopi di Medical Park Antalya Hospital Complex.

• Lebih dari 31 tahun pengalaman dalam ginekologi dan kebidanan
• Terlatih dalam bedah onkologi ginekologi
• Pakar dalam kehamilan berisiko tinggi dan perawatan infertilitas
• Anggota fakultas di Universitas Gelisim

Spesialis dalam pengobatan kanker ovarium di Hisar Hospital Intercontinental, dengan pelatihan fellowship di Hacettepe University Cancer Institute.

• Menyelesaikan residensi di Istanbul Sisli Etfal Teaching and Research Hospital
• Pelatihan fellowship di institut kanker terkemuka
• Pengalaman dengan berbagai jenis kanker termasuk kanker ovarium
• Pernah bekerja di The University of Texas MD Anderson Cancer Center

Spesialis onkologi ginekologi dan bedah laparoskopi, termasuk prosedur V-Notes tanpa bekas luka di Hisar Hospital Intercontinental.

• Ahli dalam teknik ooforektomi invasif minimal
• Melakukan bedah laparoskopi canggih dan V-Notes
• Berfokus pada prosedur onkologi ginekologi
• Terampil dalam bedah pengangkatan rahim dan kista yang kompleks

Profesor Dan Grisaro berspesialisasi dalam kanker ginekologi, dengan penelitian ekstensif mengenai kanker serviks dan ovarium di Rumah Sakit Ichilov.

• Kepala Obstetri dan Ginekologi di Rumah Sakit Ichilov
• Fellowship dalam onkologi ginekologi dari Universitas Toronto
• Penulis 83 artikel ilmiah tentang kondisi ginekologi
• Anggota American Society of Gynecologic Oncology

_doctor_2820_tahun_ pengalaman dalam onkologi dan radioterapi – Dr. Auala Hubert membawa keahlian luas dalam prosedur ooforektomi di Hadassah Medical Center.

• Spesialis onkologi medis dan radioterapi
• Kepala Pusat Kanker Gastrointestinal di Hadassah
• Bersertifikat dewan dalam onkologi dan radioterapi
• Anggota Masyarakat Onkologi Klinis Israel

Dr. Alemdar berspesialisasi dalam ooforektomi dengan latar belakang yang kuat dalam onkologi medis, memastikan perawatan komprehensif bagi pasien di Medical Park Antalya Hospital Complex.

• Lulus dari Fakultas Kedokteran Universitas Kocaeli pada tahun 2006
• Menyelesaikan spesialisasi Onkologi Medis di Universitas Akdeniz pada tahun 2018
• Pengalaman luas di berbagai rumah sakit bergengsi di Turki
• Berfokus pada integrasi keahlian onkologi ke dalam prosedur bedah

Dr. Yaacov Lawrence adalah Kepala Onkologi Radiasi di Sheba Medical Center. Beliau memiliki spesialisasi dalam terapi radiasi presisi dan neuro-onkologi. Dr. Lawrence adalah pelopor bedah radio pleksus celiac untuk manajemen nyeri kanker pankreas. Beliau memegang gelar FASTRO, salah satu penghargaan tertinggi di bidang spesialisasi beliau.

• Memimpin Program Kanker Gastrointestinal di Sheba Medical Center.
• Melakukan bedah radio stereotaktik untuk tumor otak dan kanker sistem saraf.
• Penulis lebih dari 280 publikasi ilmiah tentang protokol radiasi yang dipersonalisasi.
• Menyelesaikan pelatihan fellowship onkologi radiasi di Thomas Jefferson University.

Spesialis Obstetri, Ginekologi, dan Onkologi Ginekologi – Dr. Amnon membawa keahlian terfokus dalam prosedur ooforektomi di Rambam Medical Center.

• Spesialis onkologi ginekologi
• Berpengalaman dalam operasi ginekologi yang kompleks
• Bekerja di pusat medis terkemuka di Israel

Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

1980–1985: Completed doctoral studies at Nagasaki University, Japan

1968–present: Department of Radiology, Chinese PLA General Hospital

1988: Third Prize of the Military Science and Technology Progress Award

1989–present: Member of Radiological Society of North America(RSNA)

1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

1991: Second Prize of the Military Science and Technology Progress Award

1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

1993: Granted the Lifetime Special Government Allowance of the State Council

1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

1994: Third Prize of the Military Science and Technology Progress Award

1997: Second Prize of the Military Science and Technology Progress Award

1997–2009: Standing Member of Chinese Society of Radiology

1999: Third Prize of the Military Science and Technology Progress Award

1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

2002: Second Prize of the Military Science and Technology Progress Award

2005: Third Prize of the Military Science and Technology Progress Award

Member of Radiological Society of North America(RSNA)

Standing Member of Chinese Society of Radiology

Group Leader of the Group of Intervention of Chinese Journal of Radiology

Deputy Director Member of Chinese Society of Interventional Oncology

Director Member of Beijing Medical Association Society of Interventional Radiology

Deputy Chief Editor of Chinese Journal of Medical Image Technology

Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

Awarded the Special Government Allowance of the State Council

Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

Professor Zhang Jinshan’s Academic Achievements

Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

Selected Publications by Professor Zhang Jinshan

1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.

Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.

Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.

Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.

Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.

Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.

Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.

Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.

Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

Professor Zhang Jinshan co-authored monographs

1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

Professor Zhang Jinshan’s Research project

1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.

Ahli bedah onkologi bersertifikat yang berspesialisasi dalam prosedur ooforektomi di Rumah Sakit Galenia.

• Bersertifikat oleh Conacem dengan sertifikasi hingga 2030
• Anggota Masyarakat Onkologi Meksiko (SMEO)
• Dosen universitas di Universidad Anahuac sejak 2020
• Terlatih di Centro Medico Nacional 20 de Noviembre

Onkolog ginekologi yang berspesialisasi dalam ooforektomi laparoskopi di Gachon University Gil Medical Center.

• Ahli dalam bedah ginekologi minimal invasif
• Fokus khusus pada kasus onkologi
• Melakukan teknik laparoskopi tingkat lanjut

Prof. Dr. Gül Alço adalah ahli onkologi radiasi dengan pengalaman sekitar 27 tahun. Beliau menangani kanker payudara, paru-paru, prostat, saluran pencernaan, ginekologi, sistem saraf pusat, kepala dan leher, jaringan lunak, serta tulang dengan radioterapi.

Keahliannya meliputi radioterapi adaptif dan bedah radiasi (radiosurgery). Beliau menggunakan teknik radiasi canggih untuk memberikan perawatan yang dipersonalisasi dan berbasis bukti dalam lingkungan multidisiplin yang berpusat pada pasien.

Prof. Dr. Abdullah Sakin adalah profesor onkologi medis. Beliau menangani tumor padat, termasuk kanker paru-paru, payudara, gastrointestinal, genitourinari, ginekologi, kanker kepala dan leher, serta melanoma.

Beliau memberikan perawatan yang dipersonalisasi dan berbasis bukti. Perawatannya meliputi kemoterapi, terapi target, imunoterapi, terapi hormon, dan onkologi presisi. Beliau telah menulis lebih dari 200 publikasi ilmiah dan berpartisipasi dalam penelitian klinis internasional. Pekerjaan ini memajukan perawatan kanker yang berpusat pada pasien.

Dengan pengalaman klinis yang luas selama lebih dari 20 tahun, dokter ini berspesialisasi dalam bedah umum dan onkologi. Sepanjang kariernya yang berdedikasi, dokter telah berfokus pada penyediaan perawatan bedah yang komprehensif, menangani kasus onkologi yang kompleks, dan melakukan berbagai prosedur bedah umum dengan komitmen terhadap hasil pasien dan keunggulan bedah.

Lebih dari 10.000 operasi besar telah dilakukan – Dr. Lalit berspesialisasi dalam bedah kanker invasif minimal dengan hasil yang sangat baik.

• _doctor_2291_tahun_ pengalaman dalam bedah onkologi
• Pelatihan fellowship di Tata Medical Centre untuk kanker gastrointestinal
• Asisten Profesor di State Cancer Institute dan Government Cancer Hospital
• Berbagai publikasi nasional dan internasional
• Dikenal dengan pendekatan yang etis dan ramah pasien